全球人工心臟瓣膜市场 - 市场规模（依细分市场）、占有率、监管、偿付、治疗、预测（~2033年）

世界各地老年人口的增加以及随之而来的心臟瓣膜恶化是人工心臟瓣膜市场的主要驱动因素。瓣膜性心臟病的盛行率随着年龄的成长而增加。根据严重程度，心臟瓣膜疾病可以透过手术修復或人工心臟瓣膜置换来治疗。

本报告研究和分析了全球人造心臟瓣膜市场，提供了有关主要参与者和市场占有率、主要趋势、创新产品和技术以及竞争格局的资讯。

市场模型的主要内容如下。

人工心臟瓣膜已经上市以及不断变化的竞争格局

• 对主要产业趋势的考察
• 人工心臟瓣膜市场各细分市场的年收入及市场前景（2015-2033年）
• 依细分市场划分的手术总数、单位数量、平均售价和市场价值的详细资料

全球、区域和国家层面的特定市场考察

• 依地区细分全球趋势的特定市场定性资讯和国家考察
• 人工心臟瓣膜市场的SWOT分析
• 人工心臟瓣膜市场竞争动态的考察与趋势

透过对医疗保健系统的真实、全面的了解来促进市场理解。市场进入部分还提供有关偿付政策和监管环境的讯息，能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 依国家/地区划分的偿付政策
• 各国医疗科技监理状况

目标公司

• Edwards Lifesciences Corp
• Abbott Laboratories
• Medtronic Plc
• Corcym UK Ltd
• Artivion Inc
• Lepu Medical Technology (Beijing) Co Ltd
• TTK Healthcare Ltd
• Braile Biomedica Ltda
• 其他

Prosthetic Heart Valves Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Prosthetic heart valves are a device that mimics the function of human heart valves and have a passive mode of functioning; the opening and closing of valves are responses to pressure and flow changes within the heart. Prosthetic heart valves are for patients who have a heart valvular disease where they need their valves to be replaced. Prosthetic heart valves include both Mechanical Heart Valves and Tissue or Biological Heart Valves.

The increase in the aging population across the globe and the associated valvular degeneration is a major driving factor of the Prosthetic Heart Valve market. The prevalence of valvular heart disease increases with age. Depending on the severity of the condition Valvular Heart Diseases can be treated by surgical repair or replacement procedures using prosthetic heart valves.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Prosthetic Heart Valves market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Prosthetic Heart Valves market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Prosthetic Heart Valves market.
• Competitive dynamics insights and trends provided Prosthetic Heart Valves market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, Braile Biomedica Ltda, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Prosthetic Heart Valves marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Prosthetic Heart Valves market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Prosthetic Heart Valves market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Prosthetic Heart Valves market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.